Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Honoraria | $5,500 | 4 | 71.1% |
| Food and Beverage | $2,203 | 141 | 28.5% |
| Education | $31.50 | 1 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Tris Pharma Inc | $5,767 | 10 | $0 (2023) |
| Lundbeck LLC | $374.26 | 25 | $0 (2020) |
| Allergan, Inc. | $277.03 | 25 | $0 (2020) |
| Otsuka America Pharmaceutical, Inc. | $215.31 | 12 | $0 (2020) |
| Sunovion Pharmaceuticals Inc. | $196.12 | 13 | $0 (2022) |
| Takeda Pharmaceuticals U.S.A., Inc. | $91.09 | 7 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $87.08 | 6 | $0 (2019) |
| Shire North American Group Inc | $84.44 | 6 | $0 (2019) |
| ARBOR PHARMACEUTICALS, INC. | $78.62 | 6 | $0 (2018) |
| Neos Therapeutics, LP | $71.34 | 4 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $538.30 | 4 | Tris Pharma Inc ($524.40) |
| 2022 | $5,297 | 11 | Tris Pharma Inc ($5,227) |
| 2020 | $158.75 | 10 | Otsuka America Pharmaceutical, Inc. ($41.34) |
| 2019 | $508.94 | 36 | Allergan Inc. ($114.90) |
| 2018 | $407.26 | 26 | Sunovion Pharmaceuticals Inc. ($60.85) |
| 2017 | $824.31 | 59 | Lundbeck LLC ($240.43) |
All Payment Transactions
146 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/23/2023 | Tris Pharma Inc | Dyanavel XR (Drug) | Food and Beverage | In-kind items and services | $10.26 | General |
| Category: ADHD | ||||||
| 02/16/2023 | Tris Pharma Inc | Dyanavel XR (Drug) | Food and Beverage | In-kind items and services | $14.14 | General |
| Category: ADHD | ||||||
| 01/30/2023 | Axsome Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $13.90 | General |
| 01/09/2023 | Tris Pharma Inc | Quillivant (Drug), Dyanavel XR, Quillichew ER | Honoraria | Cash or cash equivalent | $500.00 | General |
| Category: ADHD | ||||||
| 12/05/2022 | Tris Pharma Inc | Dyanavel XR (Drug) | Food and Beverage | In-kind items and services | $4.50 | General |
| Category: ADHD | ||||||
| 11/30/2022 | Tris Pharma Inc | Dyanavel XR (Drug), Quillichew ER, Quillivant | Honoraria | Cash or cash equivalent | $1,500.00 | General |
| Category: ADHD | ||||||
| 11/14/2022 | Tris Pharma Inc | Quillichew ER (Drug), Dyanavel XR, Quillivant | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: ADHD | ||||||
| 10/07/2022 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA INITIO | Food and Beverage | In-kind items and services | $17.94 | General |
| Category: CNS | ||||||
| 10/03/2022 | Tris Pharma Inc | Quillivant (Drug), Dyanavel XR, Quillichew ER | Honoraria | Cash or cash equivalent | $1,500.00 | General |
| Category: ADHD | ||||||
| 09/21/2022 | Tris Pharma Inc | Quillivant (Drug), Quillichew ER, Dyanavel XR | Food and Beverage | In-kind items and services | $97.18 | General |
| Category: ADHD | ||||||
| 07/15/2022 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $13.71 | General |
| Category: CNS | ||||||
| 07/08/2022 | Tris Pharma Inc | Quillichew ER (Drug), Quillivant, Dyanavel XR | Honoraria | Cash or cash equivalent | $2,000.00 | General |
| Category: ADHD | ||||||
| 05/12/2022 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $11.67 | General |
| Category: CNS | ||||||
| 03/26/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.67 | General |
| Category: NEUROSCIENCE | ||||||
| 03/18/2022 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $13.87 | General |
| Category: CNS | ||||||
| 02/20/2020 | Adlon Therapeutics L.P. | ADHANSIA XR (Drug) | Food and Beverage | Cash or cash equivalent | $12.45 | General |
| Category: PRESCRIPTION STIMULANT | ||||||
| 02/12/2020 | Ironshore Pharmaceuticals Inc. | JORNAY PM (Drug) | Food and Beverage | In-kind items and services | $14.35 | General |
| Category: Central Nervous Stimulant ADHD | ||||||
| 02/11/2020 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $19.43 | General |
| Category: PSYCHIATRY | ||||||
| 02/04/2020 | Lundbeck LLC | BRINTELLIX (Drug) | Food and Beverage | Cash or cash equivalent | $20.35 | General |
| Category: PSYCHIATRY | ||||||
| 02/04/2020 | Takeda Pharmaceuticals U.S.A., Inc. | VYVANSE (Drug) | Food and Beverage | In-kind items and services | $14.04 | General |
| Category: NEUROSCIENCE | ||||||
| 01/30/2020 | Adlon Therapeutics L.P. | ADHANSIA XR (Drug) | Food and Beverage | Cash or cash equivalent | $12.21 | General |
| Category: PRESCRIPTION STIMULANT | ||||||
| 01/27/2020 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $18.45 | General |
| Category: CNS | ||||||
| 01/21/2020 | Allergan, Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.06 | General |
| Category: NEUROSCIENCE | ||||||
| 01/13/2020 | Takeda Pharmaceuticals U.S.A., Inc. | VYVANSE (Drug) | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: NEUROSCIENCE | ||||||
| 01/06/2020 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $21.91 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 67 | 121 | $22,869 | $8,748 |
| 2022 | 2 | 39 | 66 | $12,372 | $4,673 |
| 2021 | 3 | 122 | 211 | $37,514 | $14,618 |
| 2020 | 3 | 96 | 165 | $28,290 | $10,853 |
All Medicare Procedures & Services
10 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 44 | 95 | $13,015 | $5,744 | 44.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 23 | 26 | $9,854 | $3,004 | 30.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 26 | 53 | $7,345 | $2,856 | 38.9% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 13 | 13 | $5,027 | $1,817 | 36.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 79 | 165 | $22,935 | $9,021 | 39.3% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 27 | 29 | $11,281 | $4,264 | 37.8% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2021 | 16 | 17 | $3,298 | $1,333 | 40.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 66 | 135 | $18,765 | $7,380 | 39.3% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 19 | 19 | $7,391 | $2,591 | 35.1% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2020 | 11 | 11 | $2,134 | $881.37 | 41.3% |
About Dr. Brian Briscoe, MD
Dr. Brian Briscoe, MD is a Psychiatry healthcare provider based in Louisville, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/01/2007. The National Provider Identifier (NPI) number assigned to this provider is 1912045212.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brian Briscoe, MD has received a total of $7,734 in payments from pharmaceutical and medical device companies, with $538.30 received in 2023. These payments were reported across 146 transactions from 24 companies. The most common payment nature is "Honoraria" ($5,500).
As a Medicare-enrolled provider, Briscoe has provided services to 324 Medicare beneficiaries, totaling 563 services with total Medicare billing of $38,892. Data is available for 4 years (2020–2023), covering 10 distinct procedure/service records.
Practice Information
- Specialty Psychiatry
- Location Louisville, KY
- Active Since 02/01/2007
- Last Updated 07/12/2019
- Taxonomy Code 2084P0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1912045212
Products in Payments
- Quillichew ER (Drug) $2,125
- Quillivant (Drug) $2,097
- Dyanavel XR (Drug) $1,545
- REXULTI (Drug) $419.28
- VRAYLAR (Drug) $289.70
- LATUDA (Drug) $196.12
- Trintellix (Drug) $126.68
- TRINTELLIX (Drug) $99.97
- Evekeo (Drug) $78.62
- Adzenys XR-ODT (Drug) $71.34
- BRINTELLIX (Drug) $59.50
- SPRAVATO (Drug) $58.53
- MYDAYIS (Drug) $57.83
- VYVANSE (Drug) $54.15
- QUILLICHEW ER (Drug) $54.06
- APLENZIN (Drug) $52.12
- NEUROSTAR TMS THERAPY (Device) $51.22
- BELSOMRA (Drug) $36.87
- Fanapt (Drug) $35.44
- Hetlioz (Drug) $35.13
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Louisville
Rifaat Elmallakh, M.d, M.D
Psychiatry — Payments: $1.7M
Robert Stewart, M.d, M.D
Psychiatry — Payments: $652,603
Dr. Stephanie Hall, Md, MD
Psychiatry — Payments: $119,799
Kelly Clark, M.d, M.D
Psychiatry — Payments: $69,292
Dr. Ora Frankel, M.d, M.D
Psychiatry — Payments: $18,544
Dr. George Kalayil, M.d, M.D
Psychiatry — Payments: $11,878